DPP4 inhibition: Preventing SARS‐CoV ‐2 infection and/or progression of COVID ‐19?-Reference-Cited by-同舟云学术

DPP4 inhibition: Preventing SARS‐CoV ‐2 infection and/or progression of COVID ‐19?

Published:2020-06-03 Issue:8 Volume:36 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Strollo Rocky¹^ORCID,Pozzilli Paolo¹²^ORCID

Affiliation:

1. Unit of Endocrinology and Diabetes, Department of Medicine Campus Bio‐Medico, University of Rome Rome Italy

2. Centre for Immunobiology, Barts and The London School of Medicine and Dentistry Queen Mary, University of London London UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3330

Reference30 articles.

1. WHO Coronavirus Disease (COVID‐19) Outbreak Situation; April 16 2020.https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/20200415‐sitrep‐86‐covid‐19.pdf?sfvrsn=c615ea20_6. Accessed April 16 2020.

2. COVID-19 and Italy: what next?

3. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

4. Prevalence and impact of diabetes among people infected with SARS-CoV-2

5. Diabetes is a risk factor for the progression and prognosis of COVID ‐19

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sitagliptin is a time-tested leading drug in the treatment of type 2 diabetes;Meditsinskiy sovet = Medical Council;2024-09-02

2. The treatment of COVID-19: lessons learned and future directions;Future Virology;2024-08-12

3. Cognitive dysfunctions in the course of SARS‑CoV‑2 virus infection, including NeuroCOVID, frontal syndrome and cytokine storm (Review);Biomedical Reports;2024-05-16

4. Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology;2024-04-04

5. Stereochemical insights into β-amino-N-acylhydrazones and their impact on DPP-4 inhibition;RSC Advances;2024